Search results
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
AOL· 17 hours agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update their formulas for fall doses, in an attempt to target the KP.2 strain ...
Moderna’s combo COVID and flu vaccine works better than stand-alone shots on the market, study finds
Market Watch· 6 days agoexperimental combination COVID and flu vaccine triggered better immune responses than stand-alone...
FDA Tells Vaccine Makers to Target New COVID Variant for Fall | Fox 11 Tri Cities Fox 41 Yakima
FOX 11/41 Yakima· 2 days agoCOVID vaccine makers will be advised to update their shots to target the KP.2 variant, an offshoot...
Is It Too Late to Buy Novavax Stock?
Motley Fool via Yahoo Finance· 2 days agoNovavax. Just be aware that the bullishness only goes so far. The consensus analyst price target on the healthcare stock is $17.50, which is only about...
FDA asks COVID vaccine makers to target KP.2 strain with updated shots
Reuters· 1 day agoThe U.S. Food and Drug Administration recommended COVID-19 vaccine makers target the KP.2 strain...
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
Zacks· 6 days agoFree Report) is one of the stocks most watched by Zacks.com visitors lately. The Zacks Medical - Biomedical and Genetics industry, to which Novavax belongs, has gained 0.9% ...
Is It Too Late to Buy Novavax Stock?
The Motley Fool via AOL· 2 days agoNovavax. Just be aware that the bullishness only goes so far. The consensus analyst price target on the healthcare stock is $17.50, which is only about 9% higher than the ...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 5 days agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA TODAY via Yahoo News· 6 days agoModerna has not said when the combination vaccine might be evaluated by the FDA. Both Pfizer-BioNTech and Novavax are studying combination vaccines ...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 22 hours agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
